Concepts (132)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Epilepsy, Rolandic | 2 | 2019 | 57 | 1.140 |
Why?
|
| Anticonvulsants | 8 | 2019 | 1923 | 0.980 |
Why?
|
| Pseudotumor Cerebri | 1 | 2021 | 107 | 0.680 |
Why?
|
| Piracetam | 2 | 2017 | 88 | 0.670 |
Why?
|
| Measles Vaccine | 1 | 2020 | 79 | 0.670 |
Why?
|
| Systemic Inflammatory Response Syndrome | 3 | 2021 | 620 | 0.650 |
Why?
|
| Corpus Callosum | 2 | 2021 | 755 | 0.640 |
Why?
|
| Eukaryotic Initiation Factor-2B | 1 | 2018 | 9 | 0.620 |
Why?
|
| Hereditary Central Nervous System Demyelinating Diseases | 1 | 2018 | 44 | 0.600 |
Why?
|
| Valproic Acid | 2 | 2017 | 443 | 0.570 |
Why?
|
| Mixed Function Oxygenases | 1 | 2017 | 265 | 0.500 |
Why?
|
| Epilepsy | 4 | 2022 | 3324 | 0.490 |
Why?
|
| Brain Diseases | 2 | 2021 | 1553 | 0.470 |
Why?
|
| Spastic Paraplegia, Hereditary | 1 | 2017 | 171 | 0.460 |
Why?
|
| Triazoles | 2 | 2018 | 905 | 0.450 |
Why?
|
| Infant, Premature | 1 | 2023 | 2124 | 0.430 |
Why?
|
| Seizures | 6 | 2022 | 2996 | 0.420 |
Why?
|
| Encephalomyelitis, Acute Disseminated | 2 | 2022 | 68 | 0.380 |
Why?
|
| Child Behavior | 1 | 2017 | 862 | 0.370 |
Why?
|
| Guillain-Barre Syndrome | 2 | 2022 | 128 | 0.350 |
Why?
|
| Genetic Association Studies | 1 | 2018 | 2742 | 0.310 |
Why?
|
| Vaccination | 1 | 2020 | 3434 | 0.290 |
Why?
|
| Analgesics, Opioid | 1 | 2023 | 3837 | 0.270 |
Why?
|
| Child | 19 | 2022 | 80863 | 0.260 |
Why?
|
| Brain Ischemia | 1 | 2019 | 3038 | 0.250 |
Why?
|
| Insulin | 1 | 2020 | 6606 | 0.250 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2020 | 3440 | 0.240 |
Why?
|
| Multiple Sclerosis | 1 | 2020 | 3245 | 0.230 |
Why?
|
| Electroencephalography | 6 | 2021 | 6309 | 0.230 |
Why?
|
| Epilepsies, Partial | 2 | 2017 | 435 | 0.220 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2019 | 3742 | 0.220 |
Why?
|
| Cognition Disorders | 1 | 2017 | 3985 | 0.210 |
Why?
|
| Methylprednisolone | 2 | 2021 | 387 | 0.200 |
Why?
|
| Immunoglobulins, Intravenous | 3 | 2021 | 672 | 0.200 |
Why?
|
| Turkey | 2 | 2019 | 256 | 0.190 |
Why?
|
| Kidney Diseases, Cystic | 1 | 2022 | 183 | 0.190 |
Why?
|
| Plasma Exchange | 1 | 2022 | 160 | 0.180 |
Why?
|
| Brain | 5 | 2020 | 27438 | 0.180 |
Why?
|
| Central Nervous System Infections | 1 | 2021 | 61 | 0.180 |
Why?
|
| Eye Abnormalities | 1 | 2022 | 243 | 0.170 |
Why?
|
| Olfaction Disorders | 1 | 2022 | 226 | 0.170 |
Why?
|
| Iatrogenic Disease | 1 | 2023 | 552 | 0.170 |
Why?
|
| Child, Preschool | 9 | 2021 | 42623 | 0.160 |
Why?
|
| Dioxolanes | 1 | 2018 | 23 | 0.160 |
Why?
|
| Spasm | 1 | 2019 | 131 | 0.160 |
Why?
|
| Adolescent | 14 | 2022 | 89168 | 0.150 |
Why?
|
| Acid Ceramidase | 1 | 2017 | 21 | 0.150 |
Why?
|
| C-Peptide | 1 | 2020 | 444 | 0.150 |
Why?
|
| Myoclonic Epilepsies, Progressive | 1 | 2017 | 13 | 0.150 |
Why?
|
| Epilepsies, Myoclonic | 1 | 2018 | 85 | 0.150 |
Why?
|
| Measles | 1 | 2020 | 181 | 0.150 |
Why?
|
| Lafora Disease | 1 | 2017 | 8 | 0.150 |
Why?
|
| Hallucinations | 1 | 2020 | 375 | 0.150 |
Why?
|
| Protein Tyrosine Phosphatases, Non-Receptor | 1 | 2017 | 69 | 0.140 |
Why?
|
| Follow-Up Studies | 4 | 2019 | 39430 | 0.140 |
Why?
|
| Stroke | 1 | 2019 | 9791 | 0.140 |
Why?
|
| Perinatal Care | 1 | 2019 | 245 | 0.130 |
Why?
|
| Cerebral Palsy | 1 | 2021 | 478 | 0.130 |
Why?
|
| Wechsler Scales | 1 | 2017 | 258 | 0.130 |
Why?
|
| Infant | 5 | 2023 | 36497 | 0.130 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2021 | 36840 | 0.130 |
Why?
|
| Exanthema | 1 | 2020 | 504 | 0.130 |
Why?
|
| Acetamides | 1 | 2017 | 260 | 0.130 |
Why?
|
| Spasms, Infantile | 1 | 2019 | 301 | 0.120 |
Why?
|
| Abnormalities, Multiple | 1 | 2022 | 1424 | 0.120 |
Why?
|
| Gadolinium | 1 | 2020 | 965 | 0.120 |
Why?
|
| Humans | 28 | 2023 | 768451 | 0.120 |
Why?
|
| Muscular Atrophy, Spinal | 1 | 2017 | 261 | 0.120 |
Why?
|
| Parkinsonian Disorders | 1 | 2017 | 285 | 0.120 |
Why?
|
| Cerebral Infarction | 1 | 2019 | 983 | 0.110 |
Why?
|
| Mutation | 5 | 2022 | 30243 | 0.110 |
Why?
|
| Remission Induction | 1 | 2020 | 2408 | 0.110 |
Why?
|
| Demyelinating Diseases | 1 | 2016 | 359 | 0.110 |
Why?
|
| Retrospective Studies | 11 | 2022 | 81834 | 0.110 |
Why?
|
| Female | 18 | 2021 | 396943 | 0.110 |
Why?
|
| Male | 17 | 2021 | 364781 | 0.110 |
Why?
|
| Fever | 1 | 2020 | 1622 | 0.100 |
Why?
|
| Encephalitis | 1 | 2016 | 441 | 0.100 |
Why?
|
| Dyspnea | 1 | 2020 | 1352 | 0.100 |
Why?
|
| Homozygote | 1 | 2017 | 1779 | 0.100 |
Why?
|
| Disease Progression | 2 | 2020 | 13655 | 0.100 |
Why?
|
| Immunologic Factors | 1 | 2020 | 1600 | 0.090 |
Why?
|
| Phenotype | 3 | 2018 | 16712 | 0.090 |
Why?
|
| Glucocorticoids | 1 | 2020 | 2170 | 0.090 |
Why?
|
| Infant, Newborn | 2 | 2023 | 26395 | 0.090 |
Why?
|
| Case-Control Studies | 2 | 2019 | 22293 | 0.090 |
Why?
|
| Benzodiazepines | 1 | 2016 | 1139 | 0.080 |
Why?
|
| Pilot Projects | 1 | 2023 | 8730 | 0.080 |
Why?
|
| Pedigree | 1 | 2017 | 4545 | 0.080 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2019 | 6035 | 0.080 |
Why?
|
| Developmental Disabilities | 1 | 2017 | 1516 | 0.080 |
Why?
|
| Autoantibodies | 1 | 2016 | 2131 | 0.070 |
Why?
|
| Vitamin D Deficiency | 1 | 2017 | 1389 | 0.070 |
Why?
|
| Reproducibility of Results | 2 | 2023 | 20231 | 0.070 |
Why?
|
| Contrast Media | 1 | 2020 | 5336 | 0.070 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 6320 | 0.060 |
Why?
|
| Diagnosis, Differential | 2 | 2017 | 13026 | 0.060 |
Why?
|
| Treatment Outcome | 6 | 2021 | 65409 | 0.060 |
Why?
|
| Neuropsychological Tests | 1 | 2017 | 7134 | 0.060 |
Why?
|
| Vitamin D | 1 | 2017 | 3311 | 0.050 |
Why?
|
| Plasmapheresis | 1 | 2022 | 207 | 0.050 |
Why?
|
| Smell | 1 | 2022 | 261 | 0.040 |
Why?
|
| Gastrostomy | 1 | 2021 | 325 | 0.040 |
Why?
|
| Muscle Weakness | 1 | 2021 | 415 | 0.040 |
Why?
|
| Prospective Studies | 2 | 2019 | 54914 | 0.040 |
Why?
|
| Risk Factors | 3 | 2019 | 74915 | 0.030 |
Why?
|
| Cytoskeletal Proteins | 1 | 2022 | 1337 | 0.030 |
Why?
|
| Pregnancy | 1 | 2019 | 30179 | 0.030 |
Why?
|
| Syndrome | 1 | 2022 | 3278 | 0.030 |
Why?
|
| Cerebellum | 1 | 2022 | 1515 | 0.030 |
Why?
|
| Enteral Nutrition | 1 | 2021 | 804 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2021 | 1797 | 0.030 |
Why?
|
| Antigens, Neoplasm | 1 | 2022 | 2003 | 0.030 |
Why?
|
| Central Nervous System | 1 | 2022 | 1348 | 0.030 |
Why?
|
| Nutritional Status | 1 | 2021 | 1623 | 0.030 |
Why?
|
| Status Epilepticus | 1 | 2017 | 464 | 0.020 |
Why?
|
| Retina | 1 | 2022 | 2663 | 0.020 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 1 | 2016 | 905 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2022 | 3463 | 0.020 |
Why?
|
| Disease Management | 1 | 2021 | 2533 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 2021 | 2723 | 0.020 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2021 | 2823 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2017 | 4861 | 0.020 |
Why?
|
| Proteins | 1 | 2022 | 6008 | 0.020 |
Why?
|
| Aged | 1 | 2020 | 171520 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 2016 | 4417 | 0.010 |
Why?
|
| Comorbidity | 1 | 2017 | 10601 | 0.010 |
Why?
|
| Quality of Life | 1 | 2022 | 13497 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2017 | 14766 | 0.010 |
Why?
|
| Adult | 2 | 2022 | 223542 | 0.010 |
Why?
|
| Time Factors | 1 | 2017 | 40271 | 0.010 |
Why?
|
| Young Adult | 1 | 2021 | 60045 | 0.010 |
Why?
|
Concepts
(132)
Derived automatically from this person's publications.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_